SCHEMBL14029306

SCHEMBL14029306

CC(=O)c1sc(N)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 5/20 0.45
HPGD P15428 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 1/20 0.45
MAPT P10636 4/20 0.41
RXFP1 Q9HBX9 2/20 0.41
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
POLB P06746 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
SLC14A1 Q13336 1/20 0.36
MAPK14 Q16539 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ATM Q13315 1/20 0.35
DHODH Q02127 1/20 0.35
CISD2 Q8N5K1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14507422 0.83 IKBKB (0.45) ALDH1A1HPGDMAPTPOLBMEN1
SCHEMBL243572 0.83 KDM4E (0.42) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL4621697 0.81 KDM4E (0.41) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL24630402 0.78 FFAR1 (0.34) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL381164 0.78 MAPK14 (0.52) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL26041025 0.78 MAPK14 (0.33) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL4605599 0.78 ALDH1A1 (0.41) ALDH1A1HPGDSMN1; SMN2HTTLMNA
SCHEMBL102004 0.77 ALDH1A1 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2HTT
Hydrochloric Acid SCHEMBL5445499 0.76 MAPK14 (0.51) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL26242918 0.75 KDM4E (0.39) KDM4EALDH1A1HPGDSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes SMITHKLINE BEECHAM CORPORATION 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes CYP3A4, CYP2C19, CYP2B6 KDM4E 787/4885ALDH1A1 178/4885HPGD 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.